TIFFANI DOTSON: Open Payments
NPI 1851972962 · KINGSPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,939 in 138 payments from 11 companies in 2025. Trend: 2023 $1,029 · 2024 $699 · 2025 $1,939
Food & beverage: $1,763Education: $176
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $296 |
| ABBVIE INC. | 33 | $259 |
| Neurocrine BioSciences, Inc. | 16 | $257 |
| Alkermes, Inc. | 16 | $249 |
| Vanda Pharmaceuticals Inc. | 12 | $211 |
| E.R. Squibb & Sons, L.L.C. | 12 | $203 |
| Janssen Pharmaceuticals, Inc | 16 | $192 |
| Otsuka America Pharmaceutical, Inc. | 17 | $151 |
| Lundbeck LLC | 5 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
Products named: VRAYLAR, INGREZZA, ARISTADA, COBENFY, INVEGA SUSTENNA, REXULTI, HETLIOZ, FANAPT.
Industry payments across TN — which companies pay providers there.
